"We also need to offer H5N1vaccines to dairy farm workers and ensure they have access to proper PPE." "We can’t afford to keep letting this virus spill over into humans," Scarpino went on.
“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza ...
“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza ...
Some results have been hidden because they may be inaccessible to you